Meningioma in patients exposed to progestin drugs: results from a real-life screening program

Ostrom QT, Gittleman H, Truitt G et al (2018) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011–2015. Neuro-Oncol 20:1–86. https://doi.org/10.1093/neuonc/noy131

Article  Google Scholar 

Wiemels J, Wrensch M, Claus EB (2010) Epidemiology and etiology of meningioma. J Neurooncol 99:307–314. https://doi.org/10.1007/s11060-010-0386-3

Article  PubMed  PubMed Central  Google Scholar 

Baldi I, Engelhardt J, Bonnet C et al (2018) Epidemiology of meningiomas. Neurochirurgie 64:5–14. https://doi.org/10.1016/j.neuchi.2014.05.006

CAS  Article  PubMed  Google Scholar 

Pravdenkova S, Husain M (2006) Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas. J Neurosurg 105:163–173. https://doi.org/10.3171/jns.2006.105.2.163

CAS  Article  PubMed  Google Scholar 

Neumann F (1986) Pharmacology of antiandrogens. J Steroid Biochem 25:885–895. https://doi.org/10.1016/0022-4731(86)90320-1

CAS  Article  PubMed  Google Scholar 

Mueck AO, Sitruk-Ware R (2011) Nomegestrol acetate, a novel progestogen for oral contraception. Steroids 76:531–539. https://doi.org/10.1016/j.steroids.2011.02.002

CAS  Article  PubMed  Google Scholar 

Druckmann R (2009) Profile of the progesterone derivative chlormadinone acetate—pharmocodynamic properties and therapeutic applications. Contraception 79:272–281. https://doi.org/10.1016/j.contraception.2008.10.017

CAS  Article  PubMed  Google Scholar 

Catteau-Jonard S, Richard-Proust C (2012) Hyperandrogenism in adolescent girls. Endocr Dev, pp 181–193

Google Scholar 

Gazzeri R, Galarza M, Gazzeri G (2007) Growth of a meningioma in a transsexual patient after estrogen–progestin therapy. N Engl J Med 357:2411–2412. https://doi.org/10.1056/NEJMc071938

CAS  Article  PubMed  Google Scholar 

Shimizu J, Matsumoto M, Yamazaki E, Yasue M (2008) Spontaneous regression of an asymptomatic meningioma associated with discontinuation of progesterone agonist administration. Neurol Med Chir (Tokyo) 48:227–230. https://doi.org/10.2176/nmc.48.227

Article  Google Scholar 

Gonçalves AMG, Page P, Domigo V et al (2010) Abrupt regression of a meningioma after discontinuation of cyproterone treatment: Fig 1. Am J Neuroradiol 31:1504–1505. https://doi.org/10.3174/ajnr.A1978

Article  PubMed  PubMed Central  Google Scholar 

Gil M, Oliva B, Timoner J et al (2011) Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population-based cohort study: risk of meningioma among users of high doses of cyproterone acetate. Br J Clin Pharmacol 72:965–968. https://doi.org/10.1111/j.1365-2125.2011.04031.x

CAS  Article  PubMed  PubMed Central  Google Scholar 

Cea-Soriano L, Blenk T, Wallander M-A, Rodríguez LAG (2012) Hormonal therapies and meningioma: Is there a link? Cancer Epidemiol 36:198–205. https://doi.org/10.1016/j.canep.2011.08.003

CAS  Article  PubMed  Google Scholar 

Knight EJ, McDonald MJ (2013) Recurrence and progression of meningioma in male-to-female transgender individuals during exogenous hormone use. Int J Transgenderism 14:18–23. https://doi.org/10.1080/15532739.2012.725563

Article  Google Scholar 

Bergoglio MT, Gómez-Balaguer M, Almonacid Folch E et al (2013) Symptomatic meningioma induced by cross-sex hormone treatment in a male-to-female transsexual. Endocrinol Nutr 60:264–267. https://doi.org/10.1016/j.endonu.2012.07.004

Article  PubMed  Google Scholar 

Razavi HB (2014) Meningioma: the unusual growth in a transsexual patient after estrogen-progesterone therapy. SOJ Neurol 1:1–3. https://doi.org/10.15226/2374-6858/1/2/00109

Article  Google Scholar 

Papadopoulou S, Chambre C, Baudry C et al (2015) Une complication rare de l’acétate de cyprotérone chez une patiente acromégale. Ann Endocrinol 76:388–389. https://doi.org/10.1016/j.ando.2015.07.276

Article  Google Scholar 

Supartoto A, Mahayana IT, Christine RN (2016) Exposure to exogenous female sex hormones is associated with increased risk of orbito-cranial meningioma in females: a case-control study. Int J Ophthalmic Pathol 5:1–6. https://doi.org/10.4172/2324-8599.1000183

Article  Google Scholar 

Bernat A, Bonnin S, Labidi M et al (2018) Regression of giant olfactory groove meningioma and complete visual acuity recovery after discontinuation of cyproterone acetate. J Ophthalmic Vis Res 13:355. https://doi.org/10.4103/jovr.jovr_21_17

Article  PubMed  PubMed Central  Google Scholar 

Boer M, Moernaut L, Van Calenbergh F et al (2018) Variation of meningioma in response to cyproterone acetate in a trans woman. Int J Transgenderism 19:92–94. https://doi.org/10.1080/15532739.2017.1413615

Article  Google Scholar 

Mancini I, Rotilio A, Coati I et al (2018) Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review. Gynecol Endocrinol 34:456–459. https://doi.org/10.1080/09513590.2017.1395839

Article  PubMed  Google Scholar 

Nota NM, Wiepjes CM, de Blok CJM et al (2018) The occurrence of benign brain tumours in transgender individuals during cross-sex hormone treatment. Brain 141:2047–2054. https://doi.org/10.1093/brain/awy108

Article  PubMed  Google Scholar 

Roux A, Tauziede-Espariat A, Zanello M et al (2020) Symptomatic progestin-associated atypical grade II meningioma. A first case report. Neurochirurgie 66:174–178. https://doi.org/10.1016/j.neuchi.2019.12.013

CAS  Article  PubMed  Google Scholar 

Froelich S, Dali-Youcef N, Boyer P, et al (2008) Does cyproterone acetate promote multiple meningiomas? Endocr Abstr 158–161

Google Scholar 

Botella C, Coll G, Lemaire J-J, Irthum B (2015) Méningiomes intracrâniens et utilisation prolongée d’acétate de cyprotérone à dose conventionnelle chez la femme : à propos de deux cas de régression tumorale après arrêt du traitement. Neurochirurgie 61:339–342. https://doi.org/10.1016/j.neuchi.2015.05.002

CAS  Article  PubMed  Google Scholar 

Kalamarides M, Peyre M (2017) Dramatic shrinkage with reduced vascularization of large meningiomas after cessation of progestin treatment. World Neurosurg 101:814.e7-814.e10. https://doi.org/10.1016/j.wneu.2017.03.013

Article  Google Scholar 

Champagne P-O, Passeri T, Froelich S (2019) Combined hormonal influence of cyproterone acetate and nomegestrol acetate on meningioma: a case report. Acta Neurochir (Wien) 161:589–592. https://doi.org/10.1007/s00701-018-03782-4

Article  Google Scholar 

Passeri T, Champagne P-O, Bernat A-L et al (2019) Spontaneous regression of meningiomas after interruption of nomegestrol acetate: a series of three patients. Acta Neurochir (Wien) 161:761–765. https://doi.org/10.1007/s00701-019-03848-x

Article  Google Scholar 

Malaize H, Samoyeau T, Zanello M et al (2021) Evolution of the neurosurgical management of progestin-associated meningiomas: a 23-year single-center experience. J Neurooncol 152:279–288. https://doi.org/10.1007/s11060-021-03696-9

CAS  Article  PubMed  Google Scholar 

Weill A, Nguyen P, Labidi M et al (2021) Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study. Br Med J 37:1–13. https://doi.org/10.1136/bmj.n37

Article  Google Scholar 

Hoisnard L, Laanani M, Passeri T et al (2022) Risk of intracranial meningioma with three potent progestogens: a population-based case–control study. Eur J Neurol. https://doi.org/10.1111/ene.15423

Article  PubMed  Google Scholar 

Lee KS, Zhang JJY, Kirollos R et al (2022) A systematic review and meta-analysis of the association between cyproterone acetate and intracranial meningiomas. Sci Rep 12:1942. https://doi.org/10.1038/s41598-022-05773-z

CAS  Article  PubMed  PubMed Central  Google Scholar 

ANSM (2018) CSST « Acetate de cyproterone et risque de meningiomes ». In: https://ansm.sante.fr/. https://ansm.sante.fr/actualites/androcur-et-generiques-acetate-de-cyproterone-50-mg-et-100-mg-et-risque-de-meningiome-lansm-publie-des-recommandations-pour-la-prise-en-charge-des-patients

ANSM (2020) CSST « Macroprogestatifs et risque de méningiomes ». In: https://ansm.sante.fr/. https://ansm.sante.fr/evenements/comite-macroprogestatifs-et-risque-de-meningiome

Huang RY, Bi WL, Griffith B et al (2019) Imaging and diagnostic advances for intracranial meningiomas. Neuro-Oncol 21:i44–i61. https://doi.org/10.1093/neuonc/noy143

CAS  Article  PubMed  PubMed Central  Google Scholar 

Hashiba T, Suzuki T, Kato A (2009) Serial volumetric assessment of the natural history and growth pattern of incidentally discovered meningiomas. J Neurosurg 110:675–684. https://doi.org/10.3171/2008.8.JNS08481

Article  PubMed  Google Scholar 

Nakasu S, Hirano A, Shimura T, Llena JF (1987) Incidental meningiomas in autopsy study. Surg Neurol 27:319–322. https://doi.org/10.1016/0090-3019(87)90005-X

CAS  Article  PubMed  Google Scholar 

Håberg AK, Hammer TA, Kvistad KA et al (2016) Incidental intracranial findings and their clinical impact; the HUNT MRI study in a general population of 1006 participants between 50–66 years. PLoS ONE 11:1–20. https://doi.org/10.1371/journal.pone.0151080

CAS  Article  Google Scholar 

Vernooij MW (2007) Incidental findings on brain MRI in the general population. N Engl J Med. https://doi.org/10.1056/NEJMoa070972

Article  PubMed  Google Scholar 

Nahser HC, Grote W, Löhr E, Gerhard L (1981) Multiple meningiomas. Clin Comput Tomogr Observ Neuroradiol 21:259–263. https://doi.org/10.1007/BF02100156

CAS  Article  Google Scholar 

Lusins JO, Nakagawa H (1981) Multiple Meningiomas evaluated by computed tomography. Neurosurgery 9:137–141. https://doi.org/10.1227/00006123-198108000-00004

CAS  Article  PubMed  Google Scholar 

Voormolen EHJ, Champagne PO, Roca E et al (2021) Intracranial Meningiomas decrease in volume on magnetic resonance imaging after discontinuing progestin. Neurosurgery 89:308–314. https://doi.org/10.1093/neuros/nyab175

Article  PubMed  Google Scholar 

Peyre M, Gaillard S, de Marcellus C et al (2018) Progestin-associated shift of meningioma mutational landscape. Ann Oncol 29:681–686. https://doi.org/10.1093/annonc/mdx763

CAS 

留言 (0)

沒有登入
gif